focus -WSS

focus

author：leisure time 2025-09-27 16:49:52 - browse：56

Why are rich biotechs cutting costs? Has JPM Week already worn off? And what’s going to move markets in 2024?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Jason Mast joins us to discuss an emerging trend in biotech: Cash-rich startups are laying off employees and tweaking their strategies amid a tough market for venture capital. We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions.

For more on what we cover, here’s the news on Dewpoint Therapeutics; here’s more on biotech in 2024; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： UnitedHealth quietly bought dozens of outpatient centers

WSS

Change Healthcare cyberattack prompts Medicare loan program

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Case highlights the risks of experimental stem cell therapy

Readout LOUD podcast: Live from STAT Breakthrough Summit West

Solving academic medical centers' existential crisis

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

Wikipedia

focus

focus

Trump demands the U.S. pay no more for drugs than other countries … again

Change Healthcare payments predicted restored March 15

How to save PrEP access — and even expand it

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

IVF, abortion rights issues kick off Biden’s State of the Union

United colonoscopy coverage change 'may cost lives,' doctors say

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Hollywood unions extend contract negotiations for actors

Second House panel advances two

knowledge

Helping hospitals and community health centers plan for resilience

Glen Campbell's doctor discusses his public struggle with Alzheimer's

RSV shot was 90% effective at preventing hospitalizations in kids

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Change Healthcare payments predicted restored March 15

The problem with charging patients to message their doctors

entertainment

knowledge

explore

hotspot